Arthur Machlenkin
11Patents
2h-index
46Co-inventors
50Inventor score
Filing activity: Jul 28, 2003 → Dec 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7906620B2 | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines | Human Necessities | 11 | Expired |
| US7960507B2 | Tumor associated antigen peptides and use of same as anti-tumor vaccines | Human Necessities | 4 | Active |
| US10064927B2 | Allogeneic tumor cell vaccination | Human Necessities | 2 | Active |
| US8420078B2 | Methods and immunogenic cell preparations for treating antigen-associated diseases | Human Necessities | 1 | Active |
| US11225523B2 | Triple combination antibody therapies | Emerging Cross-Sectional Technologies | 1 | Active |
| US10550173B2 | PVRIG polypeptides and methods of treatment | Emerging Cross-Sectional Technologies | 1 | Active |
| US9301998B2 | Allogeneic tumor cell vaccination | Human Necessities | 1 | Active |
| US11530251B2 | Methods for cancer therapy using isolated NTB-A ectodomain polypeptides | Chemistry; Metallurgy | 0 | Active |
| US10344073B2 | Cell compositions and methods for cancer therapy | Chemistry; Metallurgy | 0 | Active |
| US12152084B2 | Triple combination antibody therapies | Emerging Cross-Sectional Technologies | 0 | Active |
| US11795209B2 | PVRIG polypeptides and methods of treatment | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.